Institution Pharmacy

Per FDA requirements, in order to order, stock, and dispense TIKOSYN new pharmacies are required to secure a one-time certification. Even if your institution has been certified prior to 2011, you are required to secure a one-time recertification. To become (re)certified you must review the following materials:

TIKOSYN Treatment Guidelines

Prescribing Information

Medication Guide
 

And sign the Institution Certification Form:

NOTE: A designated representative must complete and sign this form as part of the TIKOSYN REMS requirement.

Institution Certification Form
 

When you have reviewed all the materials, please print, sign, and mail or fax back the Certification Form. The fax number is 1-800-788-2637. After the Certification Form is received, you will receive written confirmation of receipt. In addition, before dispensing TIKOSYN, you are required to confirm that the prescriber has been certified.

Before dispensing TIKOSYN, the pharmacist is required to confirm that the prescriber has been certified. In addition, the institution must agree to stock and provide patients prior to discharge a free 7-day (14 count) supply of TIKOSYN and the Medication Guide. As a contingency, if the initiating/re-initiating institution does not have outpatient licensing privileges to dispense the free 7-day supply of TIKOSYN, the institution will ensure the patient's take home prescription is ordered and filled at a retail pharmacy prior to patient discharge.

Contact us

Should you have any questions regarding the TIKOSYN certification program, please call 1-877-TIKOSYN.

TIKOSYN is indicated for the conversion to and maintenance of normal sinus rhythm (delay in the time to recurrence of atrial fibrillation/atrial flutter) in highly symptomatic patients with atrial fibrillation/atrial flutter of greater than 1 week.

To minimize the risk of induced arrhythmia, patients initiated or re-initiated on TIKOSYN should be placed for a minimum of 3 days in a facility that can provide calculations of creatinine clearance, continuous electrocardiographic monitoring, and cardiac resuscitation (for detailed instructions regarding dose selection, see DOSAGE AND ADMINISTRATION). TIKOSYN is available only to hospitals and prescribers who have received appropriate TIKOSYN dosing and treatment initiation education (see DOSAGE AND ADMINISTRATION). For full Prescribing information, please click here.